As colitis develops, intestinal lamina propria infiltrates immune cells, causing secretion of cytokines, particularly TNF-α, a pivotal mediator of inflammation and cell death and also a key therapeutic target in IBD treatment. Here, TNF is linked to inflammatory bowel disease.